NCT06538662View on ClinicalTrials.gov

An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations

PHASE3CompletedINTERVENTIONAL
Enrollment

283

Participants

Timeline

Start Date

October 7, 2024

Primary Completion Date

January 27, 2025

Study Completion Date

April 3, 2025

Conditions
Ocular RednessEye Irritation
Interventions
DRUG

FID 123320 Ophthalmic Solution

Investigational sterile aqueous solution

DRUG

Vehicle

FID 123320 Ophthalmic Solution inactive ingredients

Trial Locations (10)

27502

NC Eye Associates, OD, PLLC, Apex

28150

CORE, Inc., Shelby

37167

Advancing Vision Research, LLC, Smyrna

38119

Total Eye Care PA, Memphis

40206

Butchertown Clinical Trials, Louisville

78249

Alamo Pediatric Eye Center, PLLC, San Antonio

80907

Vision Institute, Colorado Springs

91702

Canyon City Eyecare, Azusa

92663

Eye Research Foundation, Newport Beach

01810

Andover Eye Associates, Andover

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT06538662 - An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations | Biotech Hunter | Biotech Hunter